General inflammatory signaling pathways

General inflammatory signaling pathways represent a complex, interconnected network of molecular cascades that mediate the body's response to injury, infection, and cellular stress (Source [10, 13]). These pathways, which include the Nuclear Factor-kappa B (NF-κB), Mitogen-Activated Protein Kinase (MAPK), and Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) systems, are triggered by the activation of cell-surface receptors such as Toll-like receptors (TLRs) and cytokine receptors (Source [4, 5, 12]). Once activated, these cascades lead to the production of pro-inflammatory mediators, including cytokines, chemokines, and lipid signaling molecules, which coordinate the recruitment and activation of immune cells (Source [1, 7, 10]). While these processes are essential for host defense and tissue repair, chronic or dysregulated inflammatory signaling is a central driver in the pathogenesis of diverse conditions, including autoimmune diseases, cardiovascular disorders, neurodegeneration, and cancer (Source [2, 5, 10]). Therapeutic strategies often involve the use of small molecules or biologics to inhibit specific nodes within these pathways, such as cyclooxygenases, intracellular kinases, or the cytokines themselves (Source [4, 9, 11]). However, because these pathways also play critical roles in maintaining normal immune function and tissue homeostasis, their systemic inhibition can lead to significant safety concerns, such as increased susceptibility to opportunistic infections and impaired wound healing (Source [8, 9]).

Other names

Pro-inflammatory signaling cascadesInflammatory signaling networkCytokine signaling pathwaysInflammatory cascades

Inhibition of key signaling nodes such as cyclooxygenases, kinases (JAK, MAPK), transcription factors (NF-κB), or cytokine receptors to modulate the inflammatory response (Source [4, 9, 10, 12]).